Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
CANC
56
HOLDINGS
20%
ALSO IN AGNG
AGNG
84
HOLDINGS
13%
ALSO IN CANC
SECTOR DRIFT (CANC minus AGNG)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.4% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 3.6% | 3.5% | 3.5% |
|
ABBVIE INC | 3.3% | 3.5% | 3.3% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% | 3.2% | 3.2% |
|
JOHNSON & JOHNSON | 3.1% | 3.1% | 3.1% |
CANC Overweight Relative to AGNG
|
REVOLUTION MEDICINES, INC. | 6.0% |
|
COGENT BIOSCIENCES INC | 4.8% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.4% |
|
NOVARTIS AG | 3.8% |
|
IMMUNOME, INC. | 3.0% |
 |
GENMAB A/S SPONSORED ADR | 2.8% |
|
IDEAYA BIOSCIENCES, INC. | 2.6% |
|
CG ONCOLOGY, INC. | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
HALOZYME THERAPEUTICS INC | 2.3% |
CANC Underweight Relative to AGNG
|
NOVO NORDISK A/S-B | -3.5% |
|
WELLTOWER, INC. | -3.2% |
|
ROCHE HOLDING AG-BR | -3.2% |
|
EDWARDS LIFESCIENCES CORP | -3.2% |
|
VENTAS INC | -3.1% |
|
REGENERON PHARMACEUTICALS | -3.0% |
 |
MEDTRONIC PLC | -3.0% |
|
STRYKER CORP | -2.7% |
|
SANDOZ GROUP AG | -2.6% |
|
ALCON, INC. | -2.3% |